جست‌وجوی استاد و پژوهشگر

Baozhong Wangمشاهده پروفایل

استاد

• Vaccine Development
• Immunology
• Viral Pathogens
• +۶ مورد دیگر

Baozhong Wang is a Distinguished University Professor at Georgia State University's Institute for Biomedical Sciences. He earned his Ph.D. in Molecular Biology and Biochemistry from Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences in 2003. His research focuses on understanding how viral pathogens trigger and evade host immune responses, with particular emphasis on vaccine development using protein nanotechnology and controlled release technology. His laboratory designs nanoparticulate platforms that mimic virions by integrating both innate triggers and immunogens. Dr. Wang's recent publications (2022-2024) demonstrate significant contributions to universal influenza vaccine development, with numerous high-impact papers on protein nanoparticles, mRNA vaccines, and virus-like particles. His work frequently explores cross-protection against diverse influenza strains and the application of novel adjuvants and delivery systems. His research has established important connections between innate and adaptive immune responses in the context of influenza and HIV antigens, with a particular focus on developing broadly protective vaccine strategies. Dr. Wang maintains active collaborations with researchers including Kang SM and others, as evidenced by his co-authorship on numerous publications across immunology, virology, and nanotechnology journals. His laboratory work has significant implications for pandemic preparedness and the development of next-generation vaccines that can provide broader and longer-lasting protection against rapidly evolving viral pathogens.

Nicolas SANSONمشاهده پروفایل

دانشیار

• Soft Matter
• Polymer Chemistry
• Colloid Science
• +۴ مورد دیگر

Nicolas SANSON is a Maître de Conférence (Associate Professor) at Sorbonne University, affiliated with the Sciences et Ingénierie de la Matière Molle (SIMM) laboratory—a joint research unit (UMR 7615) of ESPCI Paris, CNRS, and Sorbonne University. Based at ESPCI Paris (10 rue Vauquelin, Paris), his work bridges fundamental soft matter research with industrial applications in petroleum engineering and biosensing. His educational background includes: PhD (2005) from Université de Montpellier II on Assemblages de copolymères à bloc double hydrophile et de cations multivalents , supervised by Dr. Corine Gérardin and Dr. François Fajula Postdoctoral research at the University of Toronto (2005) under Prof. Eugénia Kumacheva Postdoctoral research at RHODIA's CRPP (Bordeaux, 2006) under Dr. Virginie Ponsinet SANSON's research focuses on self-assembly of nanoparticles, synthesis of stimuli-responsive microgels, and physico-chemistry of macromolecular assemblies. He specializes in thermoresponsive hydrogels (particularly PNiPAM-based systems) and zwitterionic polymers, investigating structural transitions, mechanical properties, and colloidal stability. His work frequently addresses industrial challenges in enhanced oil recovery and biosensor development. Analysis of his 15 most recent publications (2011-2018) reveals consistent emphasis on LCST-type hydrogels, nanoparticle-polymer hybrids, and responsive microgels. Key trends include topology-dependent mechanical behavior in polymer networks, crack bifurcation in phase-separated systems, and colloidal stability mechanisms in zwitterionic systems. His interdisciplinary approach spans polymer chemistry, colloid science, and materials engineering, with publications in high-impact journals like Macromolecules and Advanced Materials . No formal advisees or scientific awards are documented in the source material. However, SANSON actively teaches undergraduate and graduate courses including colloidal chemistry, polymer thermodynamics, and materials science at Sorbonne University and Polytech'Paris-UPMC. He operates within the CAID (Colloïdes, Assemblages et Interfaces Dynamiques) team at SIMM laboratory, which provides advanced facilities for soft matter synthesis and characterization. The SIMM—directed by J.B. d’Espinose—hosts multiple research groups focused on non-equilibrium soft matter, polymer networks, and colloidal systems, fostering collaborative work in soft materials science.

Michelle Teplenskyمشاهده پروفایل

استادیار

• Nanomedicine
• Immune Engineering
• Vaccine Design
• +۲ مورد دیگر

Dr. Michelle Teplensky is an Assistant Professor in Biomedical Engineering and Materials Science at Boston University, where she directs research on nanomaterial-based immune engineering. Her lab develops nanoparticle platforms for next-generation vaccines and cancer immunotherapies. Research integrates nanotechnology with immunology to create programmable biomaterials that control immune cell interactions. Recent publications focus on: Spherical nucleic acid vaccine architectures Metal-organic frameworks for drug delivery Tumor microenvironment modulation Multi-antigen vaccine optimization Awards include the Beckman Young Investigator Award and AIChE 35 Under 35 recognition for innovations in nanovaccine design.

• Colloid Science
• Biophysics
• Nanotechnology
• +۵ مورد دیگر

Peter van Oostrum is a Privatdozent (Priv.Doz.Dr.) at the Institute of Colloid and Biointerface Science , Department of Biotechnology and Food Science, University of Natural Resources and Life Sciences Vienna (BOKU). His research integrates advanced optical techniques and biophysical modeling to study colloidal systems. Projects : Led key initiatives like AI-supported Holographic Environmental Water Monitoring (2025–2029) and Self-folding particle chains (2015–2020), funded by Austrian Science Fund, City of Vienna, and European Commission. Research Focus : Self-assembly of colloids, holographic microscopy, microfluidics, and force-modulated multivalent binding in bacterial systems. His work bridges nanotechnology, biophysics, and environmental monitoring. Publications : 32 peer-reviewed works, emphasizing colloidal interactions, inverse patchy particles, and holographic cytometry applications. Community Services : Active reviewer for journals like Physical Review Letters , Chemistry of Materials , and Soft Matter . Theses Supervised : Guided Bernhard Pichler’s diploma thesis on polymer-functionalized nanopores (2020).

• Virology
• Influenza
• Host-Pathogen Interactions
• +۷ مورد دیگر

Dr. C.A.M. (Xander) de Haan serves as an Associate Professor at Utrecht University's Faculty of Veterinary Medicine, where he leads research in the Department of Biomolecular Health Sciences within the Infectious Diseases & Immunology group. His work focuses on the molecular biology of influenza A virus, particularly the dynamic interactions between viral surface proteins and host sialoglycan receptors, with significant contributions to understanding viral tropism, pathogenesis, and zoonotic potential. With over two decades of experience studying coronaviruses and more recent expansion into paramyxovirus research, Dr. de Haan has established himself as a leading expert in viral entry mechanisms and host-pathogen interactions. Dr. de Haan's laboratory employs sophisticated methodologies including recombinant soluble glycoprotein mimics, solid phase binding and cleavage assays, and biolayer interferometry to characterize the functional balance between hemagglutinin and neuraminidase in influenza virus particles. His research program spans fundamental virology, translational applications, and practical disease control strategies, with particular emphasis on developing antiviral drugs and innovative vaccines against influenza A virus, respiratory syncytial virus, and elephant endotheliotropic herpesvirus. His work on elephant herpesvirus addresses a critical conservation issue affecting captive elephant populations worldwide. Analysis of Dr. de Haan's recent publication record reveals consistent thematic focus on viral receptor binding specificity, the hemagglutinin-neuraminidase functional balance, and viral adaptation mechanisms. His research demonstrates increasing attention to the development of novel vaccine platforms including nanoparticle displays of viral proteins, the molecular basis of host adaptation in animal influenza viruses, and the application of advanced biophysical techniques to quantify virus-receptor interactions. This work bridges basic science with practical applications for pandemic preparedness and disease control. As an educator, Dr. de Haan teaches courses in Infection & Immunity and Virology to Bachelor and Master students in Veterinary Medicine and Biomedical Sciences programs. He actively mentors PhD students and serves on important national scientific committees including COGEM (The Netherlands Commission on Genetic Modification) since April 2023 and the ZonMw Committee on Infectious Diseases and Resistance since February 2025, where his expertise informs national policy on critical issues related to genetic modification and infectious disease control.

Erika Eiserمشاهده پروفایل

دانشیار

• Soft Matter Physics
• Colloidal Science
• DNA Nanotechnology
• +۴ مورد دیگر

Erika Eiser is a Reader in Soft Matter Physics at the University of Cambridge, where she leads research on DNA-driven colloidal self-assembly, hydrogels, and microrheology. She previously served as an Assistant Professor at the University of Amsterdam after postdoctoral work at institutions in Montpellier and Grenoble. Eiser holds a PhD in soft matter physics from the Weizmann Institute (Israel) and a physics degree from the University of Konstanz (Germany). Her research explores: Colloidal systems : DNA-functionalized particles, kinetic assembly pathways, and emulsion rheology. Biomaterials : Hydrogel formation, protein aggregation suppression, and polysaccharide composites. Advanced characterization : Microrheology, diffusing-wave spectroscopy, and non-equilibrium molecular dynamics. Recent publications (2021–2025) focus on DNA nanotechnology, colloidal dynamics, and responsive materials, with applications in biosensing, photonics, and biomedicine. Trends include experimental/theoretical studies of self-organization, transport in soft matter, and design of functional nanocomposites. No scientific awards are listed in available sources. Eiser directs a research group at Cambridge investigating colloidal crystallization, DNA hydrogels, and optofluidic control. Collaborative projects span European institutions, including work on polymer nanocomposites and thermophoretic forces.

Leo J. van IJzendoornمشاهده پروفایل

دانشیار

• Biosensing
• Biophysics
• Nanotechnology
• +۳ مورد دیگر

Leo J. van IJzendoorn is an Associate Professor in Applied Physics and Science Education at Eindhoven University of Technology (TU/e), specializing in Particle-Based Biosensing and Biophysics. He co-leads the Molecular Biosensing for Medical Diagnostics group, a joint initiative between Applied Physics and Biomedical Engineering departments. His work focuses on biomolecule detection in complex environments using magnetic and non-magnetic particles, with applications in point-of-care diagnostics and continuous biomarker monitoring. Academically, he holds a combined Bachelor’s in Chemistry and Physics from Leiden University (1979), followed by a Master’s (1981) and PhD in Physics (1985) in Laboratory Astrophysics. He transitioned to TU/e in 1991 as an Assistant Professor, becoming Associate Professor in 1997. He co-founded the Molecular Biosensing group in 2004 and is a core member of TU/e’s Institute for Complex Molecular Systems. His research integrates thermal particle motion, magnetic actuation, and optical microscopy to study biomolecular interactions. Recent work emphasizes real-time biosensing systems and nanomechanical analysis via magnetic tweezers. Over 212 publications and 3,943 citations highlight his contributions to biosensing technologies and nanotechnology. No scientific awards are explicitly listed, though his work has garnered media attention, including coverage of lab-on-a-chip advancements and particle binding innovations. He has supervised 81 students and actively participates in interdisciplinary collaborations across chemistry, physics, and biomedical engineering.

• Nanotechnology
• Biomedical Engineering
• Drug Delivery Systems
• +۳ مورد دیگر

Dr. Hao Ye is a Researcher affiliated with the Gruppe Pané Vidal at ETH Zürich. His work focuses on advanced nanomaterials, biomedical engineering, and their applications in targeted therapies, drug delivery systems, and regenerative medicine. He specializes in developing nanoscale systems for cancer treatment, including microrobotic devices and biomimetic platforms for enhanced therapeutic efficacy. Dr. Ye's research explores interdisciplinary areas such as piezoelectric catalysis, magnetic nanomaterials, and exosome-based drug delivery. His group pioneers innovations like clinically applicable magnetic microrobots and nanoassemblies tailored for tumor microenvironment interactions. Key achievements include the design of sub-10 nm magnetic nanoparticles with pH stability, magnetoelectric microrobots for spinal cord injury repair, and bioinspired extrusion-based microfluidic fabrication of soft microrobots. His work emphasizes translating nanotechnology into practical medical solutions.

Yun Wuمشاهده پروفایل

استاد

• Cancer theranostics
• Biosensors
• Cancer biomarkers
• +۲ مورد دیگر

Professor Yun Wu is a faculty member in the Department of Biomedical Engineering at the School of Engineering and Applied Sciences, University at Buffalo. She leads the Engineered Theranostics Laboratory, focusing on nanotechnology-enabled solutions for cancer detection and treatment. Her research integrates engineering principles with biomedical applications. PhD in Chemical and Biomolecular Engineering from The Ohio State University (2009) Postdoctoral work at Ohio State's Nanoscale Science and Engineering Center (2009-2013) Assistant/Associate/Full Professor at University at Buffalo (2013-present) Yun Wu's research spans cancer theranostics through: Development of multifunctional nanoparticles for drug/gene delivery Exosome-based biosensor platforms for liquid biopsy Microfluidic methods for nanoparticle synthesis Targeted cancer therapies overcoming drug resistance Biodegradable zwitterionic polymers as PEG alternatives Surface plasmon resonance biosensors for protein/RNA detection Her 15 most recent publications demonstrate expertise in: Exosome isolation and biomarker analysis Lipoplex nanoparticle engineering Multi-drug delivery systems Photoacoustic and fluorescence imaging Pharmacokinetic modeling Clinical translation of nanotherapeutics Current research grants include: $3.1M NCI grant for Exo-PROS lung cancer detection (2022-2027) $2.4M NIBIB project on zwitterionic polymer-drug conjugates (2023-2027) $0.4M NCI grant for exosomal glycoantigen biomarkers (2022-2024) Co-investigator in $0.9M NHLBI fibrosis-on-chip system (2020-2023) Lab members include PhD, MS, and undergraduate researchers. Collaborations exist with Roswell Park Comprehensive Cancer Center and Mayo Clinic clinicians.

Sophie Beerenمشاهده پروفایل

استاد

• Supramolecular Chemistry
• Inorganic Chemistry
• Organic Chemistry
• +۵ مورد دیگر

Sophie Beeren is a Professor at the Department of Chemistry , Technical University of Denmark , with a research focus on Supramolecular Chemistry and non-covalent interactions in aqueous environments. Her work bridges Inorganic Chemistry , Organic Chemistry , and Physical Chemistry to engineer adaptive materials, host/guest systems, and functional nanostructures. Education: BSc. Honours (1st Class) in Chemistry (University of New South Wales, 2005), PhD in Chemistry (University of Cambridge, 2010) Her research emphasizes enzyme-mediated dynamic combinatorial chemistry for synthesizing cyclodextrins, including studies on pH-responsive templates , photocontrolled systems , and anion regulation in dynamic libraries. Recent work explores δ-cyclodextrin applications in nanoparticle stabilization and fluorescent probes. Her publications highlight trends in Cyclodextrin synthesis , Molecular recognition , and Dynamic systems , with collaborations spanning Carbohydrate chemistry , Nanochemistry , and Biotechnological synthesis . Scientific Awards: Carlsberg Foundation Young Researcher Fellowship (2019), Novo Nordisk Foundation Project Grant (2019), Villum Young Investigator Award (2017), L’Oreal UNESCO For Women in Science Prize (2016) Sophie leads a research group at DTU, mentoring PhD students like Nikolai Bjørn Akselvoll , Andreas Nilsson , and Juliane Sørensen . She has secured grants from the Carlsberg Foundation and Novo Nordisk Foundation , advancing applications in biotechnology and materials science.

Kevin A. Henryمشاهده پروفایل

استاد مدعو

• Antibodies and antibody responses
• Antibody antigen interactions
• Immunogenetics
• +۳ مورد دیگر

Dr. Kevin A. Henry is an Adjunct Professor in the Department of Biochemistry, Microbiology, and Immunology at the Faculty of Medicine, University of Ottawa, and a Research Officer at the National Research Council Canada. His work focuses on antibodies, antigen interactions, immunogenetics, and protein engineering, with expertise in high-throughput sequencing and biochemistry. Academic Rank: Adjunct Professor Primary Institution: University of Ottawa Research Affiliation: National Research Council Canada Research interests include: Antibody engineering and humanization Immunogenicity assessment Protein-antigen interactions High-throughput immunosequencing Structural analysis of antibody binding Publications (2018-2024) highlight expertise in: Single-domain antibody design Cancer immunotherapy (glioblastoma, pancreatic cancer) Molecular targeting strategies Structural and evolutionary immunology Applications in diagnostics and therapeutics Contact: Email: kevin.henry@nrc-cnrc.gc.ca

• Molecular Computer Simulations
• Force Field Development
• Coarse-Grained Modeling
• +۷ مورد دیگر

Alexander Lyubartsev is a Professor at the Department of Chemistry in Stockholm University, specializing in Molecular Computer Simulations . His research bridges fundamental physical chemistry with applied computational modeling, focusing on biomembranes, DNA-chromatin structures, inorganic surfaces, and multiscale method development. He teaches courses like Physical Chemistry (15 hp) and Chemical Modeling (7.5 hp) , mentoring students in computational approaches for molecular systems. Education: PhD in Molecular Biophysics (1988), St. Petersburg State University Academic Positions: 1988-1992: Researcher, St. Petersburg State University 1993-2001: Research Associate, Stockholm University 2001-2007: Associate Professor, Stockholm University 2007-present: Professor, Stockholm University His research interests center on developing computational methods for molecular systems. Key areas include: Force Field Development : Slipids for lipids, inorganic surfaces (TiO2, ZnO), zeolite interactions Coarse-Grained Modeling : DNA, nucleosome core particles, and multiscale approaches using inverse Monte Carlo Advanced Sampling : Expanded ensemble techniques, metadynamics for free energy calculations Software Development : MDynamix for molecular dynamics, MagiC for coarse-graining The articles reflect his focus on: Modeling G-quadruplex elasticity under variable ionic conditions (2017) Extending Slipids force field to polyunsaturated lipids (2016) Analyzing polyelectrolyte conformational transitions with Monte Carlo methods (2017) Investigating ion-DNA binding specificity through molecular dynamics (2016) Developing transferable potentials for gas adsorption in zeolites (2016) Studying TiO2 nanoparticle wetting mechanisms via ab initio simulations (2016) His methodological contributions include inverse Monte Carlo coarse-graining, systematic force field optimization, and multiscale approaches for chromatin components. The research directly impacts drug design, nanotoxicity modeling, and materials science applications.

Miriam Breunigمشاهده پروفایل

دانشیار

• Pharmaceutical Technology
• Nanomedicine
• Drug Delivery Systems
• +۷ مورد دیگر

apl. Prof. Dr. Miriam Breunig is Associate Professor (apl. Prof.) of Pharmaceutical Technology at the University of Regensburg, Germany, and heads a research group developing nanoparticle-based drug- and vaccine-delivery systems. Since 2023 she serves as Co-Editor-in-Chief of the European Journal of Pharmaceutics and Biopharmaceutics and in 2024 was appointed Galenus Foundation Guest Professor at MIT. Education & Career: 1996-2001: Undergraduate pharmacy studies, Ruprecht-Karls-University Heidelberg 2002-2005: Graduate researcher, Univ. Regensburg (Prof. Göpferich) 2008 & 2009: Post-doctoral fellow, MIT (Prof. Robert Langer) 2013: Habilitation in Pharmaceutical Technology, Univ. Regensburg since 2012: Akademische Rätin (Associate Professor), Dept. Pharmaceutical Technology, Univ. Regensburg Research Focus: The Breunig group engineers innovative delivery platforms for small molecules, proteins and nucleic acids. Core projects include silica- and mesoporous-silica nanoparticle vaccines against HIV-1 and SARS-CoV-2 , injectable hydrogels that provide sustained nanoparticulate antigen release for single-dose immunisation, and nanoparticle-based glaucoma therapy targeting the trabecular meshwork/Schlemm's canal with siRNA or ROCK inhibitors. Publication Trends: Recent articles (2020-2024) concentrate on multivalent antigen display on silica nanoparticles to enhance B-cell activation and durable antibody responses, long-acting hydrogel depots for HIV vaccines, ocular nanoparticle targeting for glaucoma, and mechanistic studies on nanoparticle functionalisation, ECM penetration and controlled release. Editorial & Honours: Co-Editor-in-Chief, Eur J Pharm Biopharm (since 2023) Co-Editor, same journal (2013-2023) Galenus Foundation Guest Professor, MIT (2024) Collaborations & Funding: She coordinates projects within the HIVacToGC consortium, collaborates with Prof. Mika Lindén (mesoporous silica), Prof. Rudolf Fuchshofer (ocular pharmacology) and partners at MIT, and has secured funding for vaccine and glaucoma nanomedicine initiatives.

• Antibody Engineering
• Biotherapeutics
• Immunobiophysics
• +۷ مورد دیگر

Edurne Rujas is an Ikerbasque Research Fellow at the University of the Basque Country (UPV/EHU), affiliated with the Biofisika Institute (CSIC, EHU). She leads the Antibody Engineering Group under the Fundación Biofísica Bizkaia, focusing on the development of novel antibody-based biotherapeutics for cancer and infectious diseases. Her research lies at the intersection of immunobiophysics and protein engineering, with a strong emphasis on enhancing antibody potency through multivalency, multispecificity, and membrane interface interactions. Her work has significant implications for HIV-1 and SARS-CoV-2 therapeutics and vaccine design. The trends in her recent publications reveal a consistent focus on engineering high-avidity, multimeric antibody platforms that achieve ultrapotent neutralization of viruses such as HIV-1 and SARS-CoV-2. Her studies frequently combine structural insights with functional assays to elucidate mechanisms of antibody-membrane interactions and viral entry inhibition. Ikerbasque Research Fellow Marie-Sklodowska Curie Postdoctoral Fellow Dr. Rujas has contributed to over 8 intellectual property disclosures and has co-founded the biotech company Radiant Biotherapeutics based on her platform for multimeric antibody display. Her research has been supported by prestigious fellowships and collaborative grants, though specific funding sources are not detailed in the provided text. She conducts her research at the Immunobiophysics and Antibody Engineering Laboratory within the Biofisika Institute, a prominent interdisciplinary research center in biophysics and molecular life sciences.

Sumati Bhatiaمشاهده پروفایل

مدرس ارشد

• Glycomaterials
• Antimicrobials
• Polymers
• +۷ مورد دیگر

Dr. Sumati Bhatia is a Senior Lecturer in Chemistry at Swansea University's Faculty of Science and Engineering, specializing in biomacromolecular chemistry and glycomaterials research. Her work focuses on engineering glycomaterials to combat various pathogens including Influenza A viruses, SARS-CoV-2, Herpes Simplex virus, E. coli, and Pseudomonas aeruginosa. With over 40 research articles and 7 patent applications, she leads an active research program at the intersection of chemistry, biology, physics, and emerging technologies. Her research interests center on developing glyco-based synthetic tools to gain experimental insights into infection-related processes. Dr. Bhatia's expertise spans glycomaterials, antimicrobials, polymer chemistry, drug delivery systems, sustainable chemistry, and biomacromolecules. She actively pursues interdisciplinary collaborations, particularly exploring how AI and machine learning can enhance pathogen inhibition strategies. Her work bridges fundamental chemical principles with practical biomedical applications, focusing on multivalent inhibitor design for pathogen neutralization. Analysis of her recent publications reveals a strong focus on glyco-engineered materials for pathogen inhibition, with particular emphasis on influenza viruses, SARS-CoV-2, and bacterial pathogens. Her research demonstrates sophisticated understanding of multivalent binding principles, nanomaterial design, and structure-activity relationships in pathogen inhibition. The work spans from fundamental studies of binding forces to applied therapeutic development, with increasing integration of nanotechnology approaches. Scientific Awards and Recognition: 2024-2025: Research grant from the Royal Society of Chemistry 2024-2027: Research grant from Novo Nordisk Foundation for pandemic anti-influenza drug development 2022: Research-based teaching award from Berlin University Alliance 2022: Shortlisted for the Reimund Stadler Prize 2021: Selected for ProFiL programme for professionalization of women in research and teaching Dr. Bhatia is actively involved in postgraduate supervision and has secured substantial research funding including grants from the German Science Foundation (2021-2024) and Berlin University Alliance (2020-2021). Her international collaborations span Germany, UK, USA, France, Spain, Mexico, and India, reflecting the global impact of her work. She maintains strong industry connections through her research on practical therapeutic applications of glycomaterials. Her laboratory focuses on developing innovative glyco-based materials for pathogen inhibition, with particular emphasis on multivalent binding principles. The research group employs interdisciplinary approaches combining synthetic chemistry, biophysical characterization, and biological testing to develop next-generation antimicrobial and antiviral materials. Current projects include development of pandemic-ready anti-influenza therapeutics and novel materials for combating antibiotic-resistant bacteria.